Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Athenex, Inc. | d358380dex231.htm |
| EX-10.14.3 - EX-10.14.3 - Athenex, Inc. | d358380dex10143.htm |
| EX-10.6 - EX-10.6 - Athenex, Inc. | d358380dex106.htm |
| EX-10.5 - EX-10.5 - Athenex, Inc. | d358380dex105.htm |
| EX-5.1 - EX-5.1 - Athenex, Inc. | d358380dex51.htm |
| EX-3.4 - EX-3.4 - Athenex, Inc. | d358380dex34.htm |
| EX-3.2 - EX-3.2 - Athenex, Inc. | d358380dex32.htm |
| EX-1.1 - EX-1.1 - Athenex, Inc. | d358380dex11.htm |
| S-1/A - AMENDMENT NO.2 TO THE FORM S-1 - Athenex, Inc. | d358380ds1a.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Athenex, Inc.
Buffalo, New York
We consent to the inclusion in this Amendment No. 2 to Registration Statement (No. 333-217928) on Form S-1 of Athenex, Inc. of our report dated December 13, 2016, relating to the combined financial statements of Polymed Therapeutics, Inc (Polymed) and Chongqing Taihao Pharmaceutical Co. Ltd. (Taihao) as of and for the years ended December 31, 2014 and 2013, appearing in the Registration Statement (No. 333-217928) on Form S-1 filed by Athenex, Inc. on June 2, 2017.
We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ FREED MAXICK CPAs, P.C.
Buffalo, New York
June 2, 2017